Microbiome and Immunotherapy for NSCLC

Episode
270
Soundcloud
Share

This episode of Lung Cancer Considered takes an in-depth look at the microbiome-- what is it, and why is it important to lung cancer clinicians and researchers? The microbiome has been implicated in the pathogenesis of disease, but much is still unknown about it, including how and whether it affects patients with lung cancer.

Guest
Stephen Liu
Stephen Liu

MD

Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Arielle Elkrief
Arielle Elkrief

MD

Oncologue médicale + clinicienne-chercheuse
Université de Montréal
Bertrand Routy
Bertrand Routy

MD

Director of the Laboratory of Immunotherapy and Oncomicrobiome
CRCHUM
Associate Clinical Professor at the Universite de Montreal